Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2JNW

Solution structure of a ERCC1-XPA heterodimer

Summary for 2JNW
Entry DOI10.2210/pdb2jnw/pdb
Related2A1I
DescriptorDNA excision repair protein ERCC-1, DNA-repair protein complementing XP-A cells (2 entities in total)
Functional Keywordsercc1, xpa, ner, recruitment, dna binding protein
Biological sourceHomo sapiens (human)
More
Cellular locationNucleus: P07992 P23025
Total number of polymer chains2
Total formula weight16639.05
Authors
Tsodikov, O.V.,Ivanov, D.,Orelli, B.,Staresincic, L.,Scharer, O.D.,Wagner, G. (deposition date: 2007-02-07, release date: 2007-10-30, Last modification date: 2023-12-20)
Primary citationTsodikov, O.V.,Ivanov, D.,Orelli, B.,Staresincic, L.,Shoshani, I.,Oberman, R.,Scharer, O.D.,Wagner, G.,Ellenberger, T.
Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA
Embo J., 26:4768-4776, 2007
Cited by
PubMed Abstract: The nucleotide excision repair (NER) pathway corrects DNA damage caused by sunlight, environmental mutagens and certain antitumor agents. This multistep DNA repair reaction operates by the sequential assembly of protein factors at sites of DNA damage. The efficient recognition of DNA damage and its repair are orchestrated by specific protein-protein and protein-DNA interactions within NER complexes. We have investigated an essential protein-protein interaction of the NER pathway, the binding of the XPA protein to the ERCC1 subunit of the repair endonuclease ERCC1-XPF. The structure of ERCC1 in complex with an XPA peptide shows that only a small region of XPA interacts with ERCC1 to form a stable complex exhibiting submicromolar binding affinity. However, this XPA peptide is a potent inhibitor of NER activity in a cell-free assay, blocking the excision of a cisplatin adduct from DNA. The structure of the peptide inhibitor bound to its target site reveals a binding interface that is amenable to the development of small molecule peptidomimetics that could be used to modulate NER repair activities in vivo.
PubMed: 17948053
DOI: 10.1038/sj.emboj.7601894
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

250059

PDB entries from 2026-03-04

PDB statisticsPDBj update infoContact PDBjnumon